Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucid Biotechnology Advisors is a private biotechnology consulting firm focused on chemistry, manufacturing, and controls (CMC), technical development, quality, and regulatory strategy for emerging life science companies. The firm advises clients from discovery through commercialization, with stated expertise in gene therapy, biologics manufacturing, oligonucleotides, combination products, and other novel biotechnology modalities. Its services include process development, analytical characterization, formulation, manufacturing strategy, technology transfer, quality systems, risk management, due diligence, and regulatory guidance. The company appears to operate as a specialist advisory business rather than a therapeutics developer, and it does not publicly present an internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lucid Biotechnology Advisors.